2009 Statistical Analysis
PROFILE OF DRUG ABUSERS
(Facility based)
CY 2009
AGE : Mean age of 28 years
SEX : Ratio of male to female 10:1
CIVIL STATUS : Single 58.02%
OCCUPATION : Unemployed 35.97%
EDUCATIONAL ATTAINMENT : High School Level 30.06%
ECONOMIC STATUS:Average monthly family income P16,290.80
PLACE OF RESIDENCE : Urban (specifically NCR 47.92%)
DURATION OF DRUG TAKING : More than six (6) years
NATURE OF DRUG – TAKING : Poly drug use**
DRUGS OF ABUSE : Methamphetamine Hydrochloride (Shabu)
Cannabis (Marijuana)
Inhalants (Contact Cement Adhesive)
*Residential and Out-Patient Facilities
**Poly drug users – abuse drugs one after the other or in combination with other intoxicating substances.
DEMOGRAPHIC CHARACTERISTICS
There were more males than female clients with a ratio of 10:1, with a mean age of 28 years old. The youngest center client was 10 years old while the eldest was 74 years old. The highest percent belong to age group of 15 to 19 years old with 569 or 19.22%.
More than half of the center clients were single (58.02%) followed by married (25.50%), 9.15% had live-in partners and 6.08% were separated prior to rehabilitation.
As to educational attainment, 890 or 30.06% have reached high school level while 794 or 26.82% were able to reach college level.
With regard to the status of employment, 35.97% were unemployed and 18.95% were either skilled or unskilled workers prior to their stay in the centers. Their average monthly family income is Php 16,290.80.
REPORTED CASES BY GENDER
(Facility – Based)
CY 2009
TYPE OF ADMISSION | NO. | % | NO. | % | NO. | % |
NEW ADMISSIONS | 1,799 | 60.76 | 214 | 7.23 | 2,013 | 67.98 |
READMISSIONS | 458 | 15.47 | 30 | 1.01 | 488 | 16.48 |
OUT – PATIENT | 425 | 14.35 | 35 | 1.18 | 460 | 15.54 |
T O T A L | 2,682 | 90.58 | 279 | 9.42 | 2,961 | 100.00 |
* Total Reported Cases from Residential and Out-Patient Facilities
CY 2009 ANALYSIS
For the year 2009, a total of 2,961 cases were reported by the different rehabilitation facilities nationwide. Of this number, 67.98% or 2,013 were new admission, 16.48% or 488 were relapse cases and 15.54% or 460 were referrals from outpatient facilities.
A downward trend can be seen since 2006. The decline maybe attributed to the following: People cannot afford the cost of treatment; there is misconception on what goes on inside treatment and rehabilitation facilities, and the stereotype “denial syndrome” common among drug dependents, where they insist that they are in control of their drug-taking behavior and that there is no need for them to undergo any form of treatment. Another reason for the decline can be credited to the relentless efforts of the government to eradicate the drug problem as supported by the data on the increased operations conducted and the development and implementation of preventive education programs for different target groups.
MOST COMMONLY USED/ABUSED DRUGS/SUBSTANCES
(Facility Based)
CY 2009
DRUGS USED / ABUSED | NEW ADMISSIONS | RE-ADMISSIONS | OUT-PATIENT | GRAND TOTAL | % based on the total number of responses (3,908) | % based on the total number of admissions (2,961) |
1. Methamphetamine Hydrochloride(Shabu) | 1,284 | 394 | 214 | 1,892 | 48.41 | 63.90 |
2. Cannabis (Marijuana) | 875 | 211 | 291 | 1,377 | 35.24 | 46.50 |
3. Inhalants (Contact Cement Ex.: Rugby) | 195 | 25 | 60 | 280 | 7.16 | 9.46 |
4. Benzodiazepines | 87 | 33 | 8 | 128 | 3.28 | 4.32 |
5. Nalbuphine Hydrochloride (Nubain) | 43 | 4 | 47 | 1.20 | 1.59 | |
6. MDMA (Ecstasy) | 36 | 9 | 2 | 47 | 1.20 | 1.59 |
7. Cocaine | 29 | 14 | 1 | 44 | 1.13 | 1.49 |
8. Cough / Cold Preparations | 19 | 4 | 2 | 25 | 0.64 | 0.84 |
9. Ketamine | 9 | 2 | 11 | 0.28 | 0.37 | |
10. Solvent | 4 | 6 | 1 | 11 | 0.28 | 0.37 |
* Total Reported Cases from Residential and Out-Patient Facilities
Methamphetamine Hydrochloride commonly known as “Shabu” is still the most drug of abuse with 1,892 cases, followed by Cannabis or Marijuana with 1,377 cases. Abuse of Contact Cement like rugby with 280 cases was also noted. The nature of drug taking remained to be poly-drug use.
The routes of administration are inhalation/sniffing and oral ingestion.